Evaluation of pooled fibrin sealant for ear surgery

American Journal of Otology

Volumn 18, Issue 5, 1997, Pages 660-664

  Siedentop, Karl H ^a,c   Chung, Samuel E ^a   Park, John J ^a   Sanchez, Benito ^a   Bhattacharya, Tapan ^a   Marx, Gerard ^b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Melville Biologics Inc   (United States)

^c Dept Otolaryngol Hd Neck Surg ^*  (United States)

Author keywords

Ear surgery; Pooled fibrin sealant

Indexed keywords

FIBRINOGEN; SEALANT; THROMBIN; TISSUE ADHESIVE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DURA MATER; EAR SURGERY; FIBRIN CLOT; FREEZING; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CATTLE; EAR; FIBRIN TISSUE ADHESIVE; FIBRINOGEN; HUMANS; RATS; THROMBIN;

EID: 0030805393     PISSN: 01929763     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Siedentop KH. Tissue adhesive histoacryl (2-cyano-butyl-acrylate) in experimental middle ear surgery. Am J Otol 1980; 2:77-87.
2. Staindl O. Tissue adhesion with highly concentrated fibrinogen in otolaryngology. Ann Otol 1979;88:413-8.
3. Ortel TL, Charles LA, Keller FG, et al. Topical thrombin and acquired coagulation factor inhibitors: clinical spectrum and laboratory diagnosis [Review]. Am J Hematol 1994;45(2):128-35.
4. Bänninger H, Hardegger T, Tobler A, et al. Fibrin glue in surgery: frequent development of inhibitors of bovine thrombin and human factor V. Br J Haematol 1993;85(3):527-32.
5. Cmolik BL, Spero JA, Magovern GJ, et al. Redo cardiac surgery: late bleeding complications from topical thrombin-induced factor V deficiency. J Thorac Cardiovasc Surg 1993;105(2):222-7.
6. Siedentop KH, Harris DM, Loewy A. Experimental use of fibrin tissue adhesive in middle ear surgery. Laryngoscope 1983;93:1310-3.
7. Siedentop KH, Harris DM, Sanchez B. Autologous fibrin tissue adhesive. Laryngoscope 1985;95:1074-6.
8. Siedentop KH, Harris DM, Ham KR, et al. Extended experimental and preliminary surgical findings with autologous fibrin tissue adhesive made from patient's own blood. Laryngoscope 1986;96:1062-4.
9. Siedentop KH, Harris DM, Sanchez B. Autologous fibrin tissue adhesive: factors influencing bonding power. Laryngoscope 1988;98: 731-3.
10. Harris DM, Siedentop KH, Ham KR, et al. Autologous fibrin tissue adhesive: biodegradation and systemic effects. Laryngoscope 1987; 97:1141-4.
11. Siedentop KH, Park JJ, Sanchez B. An autologous fibrin tissue adhesive with greater bonding power. Arch Otolaryngol Head Neck Surg 1995;121:769-72.
12. Marx G, Mou X, Fred R. Protecting fibrinogen with rutin during UVC irradiation for viral inactivation. Photochem Photobiol 1996; 63(4):541-6.
13. Marx G, Mou X, Medina-Sanchez E, et al. Biochemical, biophysical and biological parameters of multiply virally inactivated fibrin glue (abstract). Fibrin Sealant Characteristics and Clinical Uses, Bethesda, MD, 1994 (Symposium).
14. Marx G, Blankenfeld A. Kinetic and mechanical parameters of pure and cryoprecipitate fibrin. Blood Coag Fibrinolysis 1993;4:73-8.
15. Sierra DH, Feldman DS. A method to determine shear adhesive strength of fibrin sealants. J Appl Biomat 1992;3:147-51.